Description
Chantix (varenicline tartrate) is a smoking cessation products agent listed in our Smoking cessation products directory and prescribed for conditions within smoking cessation products (1.1) (2.1). Administered via the oral route, Chantix is available for delivery to U.S. residents through Canadian Pharmacy Store with a valid prescription. Review the clinical fact table, dosage directions, cautions, drug interactions, side effects, and official regulatory sources below.
Chantix is a medication containing the active pharmaceutical ingredient varenicline tartrate, classified pharmacologically as a smoking cessation products agent (2.1). It is clinically indicated for the management of conditions within smoking cessation products as part of a comprehensive treatment plan supervised by a licensed healthcare provider (2.1).
Within the Smoking cessation products section of our catalogue, patients and prescribers frequently review Chantix alongside related therapies such as Varenicline Starter Pack, Varenicline Tartrate, Nicoderm CQ (Nicotine), and Nicorette Gum (Nicotine).
Official Indications and Usage
Chantix is indicated for use as an aid to smoking-cessation treatment. ( 1 and 2.1 ). (1.1)
Mechanism of Action and Pharmacology
Varenicline binds with high affinity and selectivity at α4β2 neuronal nicotinic acetylcholine receptors. The efficacy of Chantix in smoking cessation is believed to be the result of varenicline's activity at α4β2 sub-type of the nicotinic receptor where its binding produces agonist activity, while simultaneously preventing nicotine binding to these receptors. Electrophysiology studies in vitro and neurochemical studies in vivo have shown that varenicline binds to α4β2 neuronal nicotinic acetylcholine receptors and stimulates receptor-mediated activity, but at a significantly lower level than nicotine. Varenicline blocks the ability of nicotine to activate α4β2 receptors and thus to stimulate the central nervous mesolimbic dopamine system, believed to be the neuronal mechanism underlying reinforcement and reward experienced upon smoking. (1.1)
Ordering Chantix from Canada for U.S. Delivery
U.S. patients can order Chantix (Varenicline) in U.S. dollars with a valid prescription from a U.S.-licensed clinician. Your card is only charged after your prescription passes pharmacist safety checks and is ready to ship.
Step 1
Send Your Prescription
- Valid Rx required from a U.S.-licensed physician, NP, or PA (Rx rules).
- Upload Rx online, request a pharmacy transfer, or have your doctor fax (844) 666 – 6819.
- Order up to a 90-day personal-use supply per shipment (refill planning).
Step 2
Pharmacist Safety Check
- Multi-point dosing and interaction review completed in under 1 business day.
- Mandatory licensed pharmacist consultation via phone, voicemail, or text before dispatch.
- Verified under our Pharmacy Safety Standards.
Step 3
$14.99 USD Tracked Parcel
- Packed in discreet protective packaging for a flat $14.99 USD per order ($29.99 if combined with cold-chain).
- Tracked via Canada Post and USPS: 3 to 7 business days from Canada (7 to 14 days from international partners).
- Review full shipping and delivery details.
Step 4
U.S. Street Delivery & Payment
- Delivered to any physical U.S. street address with signature upon delivery (no P.O. Boxes).
- You see and approve the country of origin upfront before your card is charged.
- Report any delayed or damaged parcel within 48 hours for prompt resolution.
Fact Table
| Clinical Specification | Details |
|---|---|
| Brand / Product Name | Chantix |
| Chemical / Generic Name | Varenicline Tartrate |
| Pharmacological Class | Smoking cessation products agent |
| Therapeutic Category | Smoking cessation products |
| Molecular Weight | 361.35 g/mol (2.1) |
| Protein Binding | ~20% (1.1) |
| Elimination Half-Life | ~24 hours (1.1) |
| Time to Peak Plasma Level (Tmax) | 3-4 hours (2.1) |
| Legal Status | Rx-Only (Prescription Required) |
| Regulatory Reference Authorities | U.S. FDA (DailyMed), Health Canada (DPD) |
| Routes of Administration | Oral |
| Dosage Forms & Strengths | Capsular, biconvex tablets: 0.5 mg (white to off-white, debossed with " Pfizer " on one side and "chx 0.5" on the other side) and 1 mg (light blue |
| Primary Indications | Conditions Within Smoking Cessation Products |
| Pregnancy & Breastfeeding | Consult Doctor / Prescriber before use |
| FDA UNII Identifier | 82269ASB48 |
| NLM RxNorm Concept ID (RxCUI) | 636671, 636676, 637188, 637190 |
| FDA Application License | NDA021928 |
| Official DailyMed SetID | f0ff4f27-5185-4881-a749-c6b7a0ca5696 |
| Catalogue Index Links | Letter C Index · All Medications · All Categories |
Directions
Dosage and Administration Overview
- Begin Chantix dosing one week before the date set by the patient to stop smoking. Alternatively, the patient can begin Chantix dosing and then quit smoking between days 8 and 35 of treatment.
- Starting Week: 0.5 mg once daily on days 1-3 and 0.5 mg twice daily on days 4-7.
- Continuing Weeks: 1 mg twice daily for a total of 12 weeks.
- An additional 12 weeks of treatment is recommended for successful quitters to increase likelihood of long-term abstinence.
- Consider a gradual approach to quitting smoking with Chantix for patients who are sure that they are not able or willing to quit abruptly. Patients should begin Chantix dosing and reduce smoking by 50% from baseline within the first four weeks, by an additional 50% in the next four weeks, and continue reducing with the goal of reaching complete abstinence by 12 weeks.
- Severe Renal Impairment (estimated creatinine clearance less than 30 mL/min): Begin with 0.5 mg once daily and titrate to 0.5 mg twice daily. (1.1)
Presentations and Strengths
Capsular, biconvex tablets: 0.5 mg (white to off-white, debossed with " Pfizer " on one side and "chx 0.5" on the other side) and 1 mg (light blue, debossed with " Pfizer " on one side and "chx 1.0" on the other side). Tablets: 0.5 mg and 1 mg. (1.1)
Administration Guidance
Take Chantix orally at the same time(s) each day as directed on your prescription label (1.1). Check with your pharmacist whether your specific formulation should be taken with a meal or on an empty stomach, and swallow extended-release or film-coated tablets whole without crushing, chewing, or splitting unless the tablet is scored and your prescriber has instructed you to do so.
Missed Dose Guidance
If you miss a scheduled dose of Chantix, follow the missed-dose instructions in the official patient leaflet or ask your pharmacist. Do not double the next dose to make up for a missed dose (2.1).
Ingredients
Active Pharmaceutical Ingredient
The active ingredient in Chantix is varenicline tartrate (2.1).
Inactive Ingredients (Excipients)
According to the U.S. FDA product labeling, formulation excipients include microcrystalline cellulose, anhydrous dibasic calcium phosphate, croscarmellose sodium, colloidal silicon dioxide, magnesium stearate, Opadry® White (1.1). Inactive ingredients can vary slightly between different manufacturers and international or generic presentations; review the dispensed carton if you have known excipient sensitivities.
Cautions and important safety information
Contraindications
Chantix is contraindicated in patients with a known history of serious hypersensitivity reactions or skin reactions to Chantix. (1.1)
Key Clinical Precautions
Before starting or continuing Chantix, discuss your complete medical history with your healthcare provider. Key clinical cautions include (1.1):
- Suicidal ideation and behavior monitoring: Patients, especially children, adolescents, and young adults starting or changing doses of centrally acting therapies, should be closely monitored for worsening mood, agitation, or emergence of suicidal thoughts.
- Cardiovascular events: Depending on the medication class and underlying medical history, patients should be monitored for signs of cardiovascular events such as chest pain, shortness of breath, sudden weakness, or slurred speech.
- Hypersensitivity and anaphylaxis: Serious allergic reactions, including anaphylaxis, angioedema, and severe rash, have been reported. Discontinue use and seek immediate medical care if swelling of the face, lips, tongue, or throat or difficulty breathing occurs.
- Angioedema: Swelling of the face, extremities, lips, tongue, glottis, or larynx can occur at any time during treatment. Airway-involving angioedema requires emergency medical intervention.
- Severe cutaneous adverse reactions (SCARs): Rare but serious skin reactions such as Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN) require immediate discontinuation at the first sign of a blistering rash, mucosal lesions, or fever.
- Seizure threshold: This medication may lower the seizure threshold or require caution in patients with a history of seizure disorders or conditions that predispose to seizures.
Pregnancy, Lactation, and Special Populations
Available data have not suggested an increased risk for major birth defects following exposure to varenicline in pregnancy, compared with women who smoke. Smoking during pregnancy is associated with maternal, fetal, and neonatal risks. In animal studies, varenicline did not result in major malformations but caused decreased fetal weights in rabbits when dosed during organogenesis at exposures equivalent to 50 times the exposure at the maximum recommended human dose (MRHD). (1.1)
Interactions
Official Drug Interaction Overview
Based on varenicline characteristics and clinical experience to date, Chantix has no clinically meaningful pharmacokinetic drug interactions (1.1):
- Other Smoking-Cessation Therapies: Safety and efficacy in combination with other smoking-cessation therapies has not been established. Coadministration of varenicline and transdermal nicotine resulted in a high rate of discontinuation due to adverse events.
- Effect of Smoking Cessation on Other Drugs: Pharmacokinetics or pharmacodynamics of certain drugs (e.g., theophylline, warfarin, insulin) may be altered, necessitating dose adjustment.
Important Interaction Categories
Concomitant use of Chantix with certain prescription medications, over-the-counter drugs, or supplements can alter how the medication works or increase the risk of side effects. Important interaction categories to review with your prescriber and pharmacist include (2.1):
- Warfarin and vitamin K antagonists (such as Coumadin (Warfarin Sodium) or Warfarin Generic in our Cardiovascular directory): Concomitant administration may alter prothrombin time and International Normalized Ratio (INR) or have additive effects on hemostasis and bleeding risk. More frequent INR monitoring and clinical observation for bleeding are recommended.
- Insulin and insulin secretagogues (such as sulfonylureas including Amaryl (Glimepiride), Glucotrol XL (Glipizide), or DiaBeta (Glyburide), as well as insulin preparations): Concomitant use can increase the risk of hypoglycemia (low blood sugar). Your prescriber may recommend blood glucose monitoring or a dose adjustment of your insulin or secretagogue.
Side effects
Like all medications, Chantix can cause side effects, although not everyone experiences them. Commonly reported side effects in clinical trials and official labeling include (1.1):
- Nausea (feeling sick): Often mild to moderate and most noticeable when starting therapy or increasing the dose; taking oral doses with food (when permitted by the label) may help.
- Vomiting: Persistent vomiting that prevents fluid intake should be reported to your clinician to prevent dehydration.
- Diarrhea (loose stools): Maintain adequate fluid and electrolyte intake; contact your prescriber if diarrhea is severe or persistent.
- Constipation: Adequate hydration and dietary fiber can help manage mild changes in bowel habits.
- Headache: Commonly reported during initial treatment; often improves as your body adjusts to the medication.
- Dizziness or lightheadedness: May occur especially when standing up quickly from a sitting or lying position (orthostatic changes); rise slowly and stay well hydrated.
Clinical Trial and Postmarketing Adverse Reactions
The following serious adverse reactions were reported in postmarketing experience and are discussed in greater detail in other sections of the labeling (1.1):
- Neuropsychiatric Adverse Events including Suicidality.
- Seizures.
- Interaction with Alcohol.
- Accidental Injury.
- Cardiovascular Events.
- Somnambulism.
- Angioedema and Hypersensitivity Reactions.
- Serious Skin Reactions In the placebo-controlled premarketing studies, the most common adverse events associated with Chantix (>5% and twice the rate seen in placebo-treated patients) were nausea, abnormal (vivid, unusual, or strange) dreams, constipation, flatulence, and vomiting. The treatment discontinuation rate due to adverse events in patients dosed with 1 mg twice daily was 12% for Chantix, compared to 10% for placebo in studies of three months' treatment.
When to Seek Immediate Medical Attention
Contact your physician or seek urgent medical care if you experience signs of a severe allergic reaction (hives, difficulty breathing, or swelling of the face, lips, tongue, or throat), severe dizziness or fainting, unexplained severe pain, or any sudden change in your clinical symptoms (2.1).
Storage and handling
What is a generic drug?
A generic medication contains the exact same active pharmaceutical ingredient (varenicline tartrate) as its brand-name counterpart and is formulated to deliver the same dosage strength, route of administration, safety profile, quality, and therapeutic performance (2.1). Regulatory authorities require generic manufacturers to demonstrate bioequivalence, meaning the generic medication releases its active ingredient into the bloodstream at virtually the same rate and to the same extent as the innovator brand.
While a generic tablet, capsule, or inhaler may differ in color, shape, scoring, or packaging due to trademark laws that govern brand appearance, its clinical mechanism and active ingredient match the reference medicine. Because generic manufacturers do not repeat the initial discovery and multi-phase clinical trial investments of the original brand, generic equivalents offer substantial cost savings for patients paying out of pocket.
Canadian Pharmacy Store delivers prescription and over-the-counter medications to U.S. residents. Browse our Smoking cessation products directory, explore all medications A-Z, review how ordering works and prescription requirements, or call 1-888-868-1920 for personal assistance matching your prescription.
Related Medications in Our Catalogue
- Varenicline Starter Pack, listed in Smoking cessation products
- Varenicline Tartrate, listed in Smoking cessation products
- Nicoderm CQ (Nicotine), listed in Smoking cessation products
- Nicorette Gum (Nicotine), listed in Smoking cessation products
- Nicorette Invisi Patches (Nicotine), listed in Smoking cessation products
- Nicorette Microtab (Nicotine), listed in Smoking cessation products
Related Categories, Directories, and Ordering Guides
- Smoking cessation products Category Directory
- Medications Starting with C
- Active Ingredient Directory
- What to prepare before a prescription order
- How to compare prescription prices without mixing up the product
- How to Order Prescription Medication
- Prescription Requirements
- Ordering Medication from Canada Guide
- Caregiver Ordering Guide
- Explore Medications
- Explore Categories
- Explore Coumadin Warfarin Sodium
- Explore Warfarin Generic
- Explore Cardiovascular
- Explore Amaryl Glimepiride
- Explore Glucotrol Xl Glipizide
- Explore Diabeta Glyburide
- Explore Diabetes
Frequently Asked Questions About Chantix
What is Chantix and what active ingredient does it contain?
Chantix is a smoking cessation products agent containing the active pharmaceutical ingredient varenicline tartrate. It is supplied for oral administration and requires a valid prescription where applicable.
How does Chantix work in the body?
Varenicline binds with high affinity and selectivity at α4β2 neuronal nicotinic acetylcholine receptors. The efficacy of Chantix in smoking cessation is believed to be the result of varenicline's activity at α4β2 sub-type of the nicotinic receptor where its binding produces agonist activity, while simultaneously preventing nicotine binding to these receptors. Electrophysiology studies in vitro and neurochemical studies in vivo have shown that varenicline binds to α4β2 neuronal nicotinic acetylcholine receptors and stimulates receptor-mediated activity, but at a significantly lower level than nicotine.
What conditions is Chantix prescribed to treat?
Chantix is primarily indicated for conditions within smoking cessation products. Your prescribing clinician determines the appropriate indication, strength, and treatment duration based on your individual diagnosis and medical history.
How should I take or use Chantix?
Follow the exact dosage, frequency, and administration instructions printed on your prescription label. Chantix is administered via the oral route. Take it consistently at the same time(s) as directed, and never adjust your dose or stop therapy without speaking with your prescriber.
What are the most common side effects of Chantix?
Commonly reported side effects of Chantix include feeling sick, vomiting, loose stools, constipation, headache, and dizziness. Most mild side effects improve as your body adjusts to treatment, but you should notify your doctor or pharmacist if symptoms persist or worsen.
What medications or substances can interact with Chantix?
Important interaction categories for Chantix include warfarin and insulin. Always share a complete list of your prescription drugs, over-the-counter medicines, vitamins, and herbal supplements with your pharmacist before starting treatment.
Can Chantix be used during pregnancy or breastfeeding?
If you are pregnant, planning to become pregnant, or breastfeeding, consult your prescribing physician before using Chantix to weigh the clinical benefits and potential risks.
Do I need a prescription to buy Chantix online from Canada?
Yes. A valid prescription written by a U.S.-licensed physician, nurse practitioner, or physician assistant is required to buy Chantix (Varenicline) through our licensed Canadian pharmacy partners. Valid prescriptions go through multiple safety checks in less than 1 business day, followed by a mandatory request to speak with a licensed pharmacist for a consultation (watch your phone, voicemails, and text messages).
Does Chantix have a generic equivalent (Varenicline) at a Canada pharmacy?
Yes. A lower-cost generic equivalent (Varenicline Tartrate) containing Varenicline is available alongside brand-name Chantix in our Canada pharmacy catalogue.
Generic: Varenicline Tartrate
How is Chantix shipped to U.S. residents, and how much does shipping cost?
Chantix ships in discreet protective packaging at a flat rate of $14.99 USD per order via Canada Post and USPS with full tracking (if combined in the same order with a cold-chain item, total shipping is $29.99 USD in a larger container). Once your valid prescription passes safety checks (<1 business day) and you respond to the mandatory licensed pharmacist consultation request via phone, voicemail, or text message, delivery takes 3 to 7 business days from Manitoba, Canada (or 7 to 14 business days from licensed partner pharmacies in the UK, Singapore, and Mauritius). You see and choose the country of origin before you pay, and your Visa, Mastercard, or Discover card is only charged when your order is ready to ship.
How can I send or transfer my Chantix prescription, or ask about an unlisted strength?
You can upload a clear photo or PDF of your Chantix prescription online, request a prescription transfer or direct prescriber coordination from our team, or have your prescriber fax the prescription directly to (844) 666 – 6819. You may order up to a 90-day personal-use supply per shipment. If you do not see your exact prescribed strength or manufacturer listed, call 1-888-868-1920 and our staff will check availability across our licensed pharmacy partners.
References & Official Sources
Clinical, pharmacological, and safety facts for Chantix (Varenicline Tartrate) are compiled directly from official regulatory prescribing labels and primary biomedical databases:
- (1.1) Chantix (Varenicline Tartrate), Official Prescribing Information. U.S. National Library of Medicine / U.S. Food and Drug Administration (DailyMed). Official U.S. FDA / DailyMed Structured Product Labeling (SPL). (Accessed 2026-10-29).
- (2.1) Health Canada Drug Product Database (DPD), Authorized Product Records. Health Canada / Government of Canada. Health Canada Drug Product Database & Official Product Monograph. (Accessed 2026-10-29).
